Novel 3-substituted-2-oxoindoline-based N-hydroxypropenamides as Histone Deacetylase Inhibitors and Antitumor Agents

E-ISSN： 1875-6638|11|8|725-735

ISSN： 1573-4064

Source： Medicinal Chemistry, Vol.11, Iss.8, 2015-10, pp. : 725-735

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Histone deacetylase inhibitors: novel anticancer agents

By Saunders N.A. Popa C. Serewko M.M. Jones S.J. Dicker A.J. Dahler A.L.

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 10, 1999-10 ,pp. : 1611-1621

Informa Healthcare

Access to resources Recommend Favorite

5-Aryl-1,3,4-Thiadiazole-Based Hydroxamic Acids as Histone Deacetylase Inhibitors and Antitumor Agents: Synthesis, Bioevaluation and Docking Study

Medicinal Chemistry, Vol. 11, Iss. 3, 2015-05 ,pp. : 296-304

Bentham Science Publishers

Access to resources Recommend Favorite

New Benzothiazole/thiazole-Containing Hydroxamic Acids as Potent Histone Deacetylase Inhibitors and Antitumor Agents

Medicinal Chemistry, Vol. 9, Iss. 8, 2013-01 ,pp. : 1051-1057

Bentham Science Publishers

Access to resources Recommend Favorite

Histone deacetylase inhibitors: discovery and development as anticancer agents

By Marks Paul A Dokmanovic Milos

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 12, 2005-12 ,pp. : 1497-1511

Informa Healthcare

Access to resources Recommend Favorite

Histone Deacetylase Inhibitors: Potent Anti-Leukemic Agents

Current Medicinal Chemistry, Vol. 22, Iss. 17, 2015-06 ,pp. : 2065-2074

Bentham Science Publishers

Access to resources Recommend Favorite